CN112121227A - Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface - Google Patents
Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface Download PDFInfo
- Publication number
- CN112121227A CN112121227A CN202010822010.9A CN202010822010A CN112121227A CN 112121227 A CN112121227 A CN 112121227A CN 202010822010 A CN202010822010 A CN 202010822010A CN 112121227 A CN112121227 A CN 112121227A
- Authority
- CN
- China
- Prior art keywords
- strontium
- titanium
- composite coating
- metal surface
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 title claims abstract description 68
- 239000010936 titanium Substances 0.000 title claims abstract description 68
- 229910052719 titanium Inorganic materials 0.000 title claims abstract description 67
- 239000011248 coating agent Substances 0.000 title claims abstract description 29
- 238000000576 coating method Methods 0.000 title claims abstract description 29
- 229910052712 strontium Inorganic materials 0.000 title claims abstract description 25
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 22
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims abstract description 22
- 239000002131 composite material Substances 0.000 title claims abstract description 17
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 16
- 239000002184 metal Substances 0.000 title claims abstract description 16
- VEALVRVVWBQVSL-UHFFFAOYSA-N strontium titanate Chemical compound [Sr+2].[O-][Ti]([O-])=O VEALVRVVWBQVSL-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 230000008021 deposition Effects 0.000 claims abstract description 15
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003792 electrolyte Substances 0.000 claims abstract description 12
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 7
- 239000011575 calcium Substances 0.000 claims abstract description 5
- 238000007743 anodising Methods 0.000 claims abstract description 3
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 3
- 159000000008 strontium salts Chemical class 0.000 claims abstract description 3
- 238000000151 deposition Methods 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000003647 oxidation Effects 0.000 claims description 7
- 238000007254 oxidation reaction Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 229910003514 Sr(OH) Inorganic materials 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 5
- 238000002048 anodisation reaction Methods 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 238000004070 electrodeposition Methods 0.000 claims description 4
- 238000003760 magnetic stirring Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000000137 annealing Methods 0.000 claims description 2
- 238000005137 deposition process Methods 0.000 claims description 2
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical class Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 claims description 2
- 239000007943 implant Substances 0.000 abstract description 19
- 239000000203 mixture Substances 0.000 abstract description 5
- 239000002071 nanotube Substances 0.000 abstract description 5
- 239000000758 substrate Substances 0.000 abstract description 5
- 239000011159 matrix material Substances 0.000 abstract description 2
- 235000019738 Limestone Nutrition 0.000 abstract 1
- MSBKSDYSQOAXAW-UHFFFAOYSA-N O[P].[Sr] Chemical compound O[P].[Sr] MSBKSDYSQOAXAW-UHFFFAOYSA-N 0.000 abstract 1
- 239000006028 limestone Substances 0.000 abstract 1
- UUCCCPNEFXQJEL-UHFFFAOYSA-L strontium dihydroxide Chemical compound [OH-].[OH-].[Sr+2] UUCCCPNEFXQJEL-UHFFFAOYSA-L 0.000 abstract 1
- 229910001866 strontium hydroxide Inorganic materials 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 11
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 3
- 210000000963 osteoblast Anatomy 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229910001427 strontium ion Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011173 biocomposite Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 238000010883 osseointegration Methods 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- XXUZFRDUEGQHOV-UHFFFAOYSA-J strontium ranelate Chemical compound [Sr+2].[Sr+2].[O-]C(=O)CN(CC([O-])=O)C=1SC(C([O-])=O)=C(CC([O-])=O)C=1C#N XXUZFRDUEGQHOV-UHFFFAOYSA-J 0.000 description 1
- 229940079488 strontium ranelate Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/06—Titanium or titanium alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/32—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明涉及一种钛金属表面钛酸锶/锶羟基磷灰石医用复合涂层的制备方法,包括以下步骤:将钛片用SiC砂纸逐级打磨,超声洗涤,混合酸溶液浸泡10‑15秒,再超声洗涤干燥;以预处理后的钛片为阳极,铂片电极为阴极,室温下进行阳极氧化后将钛片清洗干燥,并于管式炉中进行退火处理;将所得钛片于16ml,Sr(OH)2溶液中,200℃下水热反应1.5‑2h,取出清洗干燥;将所得钛片置于钙盐和锶盐混合电解液中进行恒流沉积,所述电解液组成为:0.034M‑0.04M的Ca(NO)3,0.02M‑0.06M的Sr(NO)3,0.025M的NH4H2PO3,0.1M的Na(NO)3。本发明钛金属表面钛酸锶/锶羟基磷灰石医用复合涂层的制备方法,首次在钛基体表面制备了含锶元素复合涂层,其中分为含锶纳米管涂层和含锶羟基磷灰石涂层,对钛基体植入体的性能有很大改善。
The invention relates to a preparation method for a strontium titanate/strontium hydroxyapatite medical composite coating on a titanium metal surface. , and then ultrasonically washed and dried; the pretreated titanium sheet was used as the anode, and the platinum sheet electrode was used as the cathode. After anodizing at room temperature, the titanium sheet was cleaned and dried, and annealed in a tube furnace; the obtained titanium sheet was placed in 16ml , in Sr(OH)2 solution, hydrothermally reacted at 200 ° C for 1.5-2 h, taken out, cleaned and dried; the obtained titanium sheet was placed in a mixed electrolyte of calcium salt and strontium salt for constant current deposition, and the electrolyte composition was: 0.034 M‑0.04M Ca(NO)3, 0.02M‑0.06M Sr(NO)3, 0.025M NH4H2PO3, 0.1M Na(NO)3. The preparation method of the strontium titanate/strontium hydroxyapatite medical composite coating on the titanium metal surface of the present invention prepares the strontium element-containing composite coating on the surface of the titanium substrate for the first time, which is divided into a strontium nanotube coating and a strontium hydroxy phosphorus coating Limestone coating, which greatly improves the performance of titanium matrix implants.
Description
技术领域technical field
本发明属于材料与生物医学交叉技术领域,具体涉及一种钛金属表面钛酸锶/锶羟基磷灰石复合医用涂层的制备方法。The invention belongs to the cross technical field of materials and biomedicine, in particular to a preparation method of a strontium titanate/strontium hydroxyapatite composite medical coating on a titanium metal surface.
背景技术Background technique
钛及钛合金因为其自身机械强度高,弹性模量低,化学惰性,是目前性能最为优异的植入体材料。由于钛及钛基合金同人体骨组织性能差异仍然较大,作为植入材料进入人体环境后仍会产生以下两方面问题:1、由于钛金属具有生物惰性,表面生物活性不理想,其促骨生成能力差,导致植入体同周围组织结合较差,时间过长时,使植入体发生松动;2、由于单独的钛金属植入体不具有杀菌抗炎性能,植入体进入体内,可能会由于细菌感染导致植入体周围产生炎症反应。目前,对钛表面进行功能改性以提高其与周围组织的骨结合能力仍是当前的研究热点。钛种植体表面的微纳米结构效应在诱导成骨细胞增殖和分化方面起主导作用,人们的主要目的是通过物理、化学手段,改变植入体钛材料表面形貌,结构,成分特性,从而达到改善植入体生物性能的目的。Titanium and titanium alloys are the most excellent implant materials at present because of their high mechanical strength, low elastic modulus and chemical inertness. Since titanium and titanium-based alloys are still quite different in performance from human bone tissue, the following two problems will still arise after entering the human environment as implant materials: 1. Due to the biological inertness of titanium metal, the surface biological activity is not ideal, and its bone-promoting Poor generation ability, resulting in poor integration of the implant with the surrounding tissue, and loosening of the implant when the time is too long; 2. Since the titanium implant alone does not have bactericidal and anti-inflammatory properties, the implant enters the body, There may be an inflammatory reaction around the implant due to bacterial infection. At present, functional modification of titanium surface to improve its osseointegration with surrounding tissues is still a current research hotspot. The micro-nano structure effect on the surface of titanium implants plays a leading role in inducing the proliferation and differentiation of osteoblasts. The main purpose of people is to change the surface morphology, structure and composition characteristics of titanium implants through physical and chemical means, so as to achieve The purpose of improving the biological properties of implants.
羟基磷灰石,简称HA,由于羟基磷灰石同人体骨骼成分磷酸钙盐的组成非常相似,生物相容性好,具有促成骨能力,目前广泛用作骨组织修复替代材料。但是,羟基磷灰石也存在缺点,如抗拉强度差,韧性低,这在很大程度上也限制了羟基磷灰石在植入体材料方面的应用。Hydroxyapatite, or HA for short, is widely used as a substitute material for bone tissue repair due to its very similar composition to calcium phosphate, a component of human bone, with good biocompatibility and osteopromoting ability. However, hydroxyapatite also has disadvantages, such as poor tensile strength and low toughness, which also limits the application of hydroxyapatite in implant materials to a large extent.
近年来,雷奈酸锶在治疗女性骨质疏松方面的应用广泛,锶在骨修复方面的作用也得到了人们的验证。对骨质疏松患者引入含锶药物后,骨折风险有明显的降低。锶是人骨骼中的一种天然微量元素,具有刺激成骨细胞分化的作用。In recent years, strontium ranelate has been widely used in the treatment of female osteoporosis, and the role of strontium in bone repair has also been verified by people. The introduction of strontium-containing drugs to patients with osteoporosis significantly reduces the risk of fractures. Strontium is a natural trace element in human bones and has the effect of stimulating the differentiation of osteoblasts.
但至今未见将锶、羟基磷灰石与钛金属相结合,以改善钛基体植入体性能的方法,如能将其有效结合,这是一种新的尝试,必将有广泛的应用价值。But so far, there is no method to combine strontium, hydroxyapatite and titanium metal to improve the performance of titanium matrix implants. If they can be effectively combined, this is a new attempt and will have a wide range of application value. .
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种钛金属表面钛酸锶/锶羟基磷灰石复合医用涂层的制备方法,以克服现有医用钛材料的抗菌性、生物相容性差的缺点。该方法是以表面阳极氧化产生均匀二氧化钛纳米管阵列,经水热改性为钛酸锶纳米管,在其表面电化学沉积一层锶掺杂羟基磷灰石的生物复合涂层,复合涂层中的锶离子随着时间逐渐释放到种植体周围环境中,能够提高种植体的促成骨性能,其表面的锶羟基磷灰石涂层结构致密,表面粗糙,相比于纯钛植入体,有利于植入体在人体内的成功植入;采用电化学同水热法相结合,条件温和,能够有效提高现有植入体的生物性能。The purpose of the present invention is to provide a preparation method of strontium titanate/strontium hydroxyapatite composite medical coating on titanium metal surface, so as to overcome the shortcomings of poor antibacterial properties and poor biocompatibility of existing medical titanium materials. In the method, a uniform titanium dioxide nanotube array is produced by surface anodic oxidation, hydrothermally modified into strontium titanate nanotubes, and a layer of strontium-doped hydroxyapatite biocomposite coating is electrochemically deposited on its surface. The strontium ions in the implant are gradually released into the surrounding environment of the implant over time, which can improve the osteogenic properties of the implant. The surface of the strontium hydroxyapatite coating has a dense structure and a rough surface. Compared with pure titanium implants, It is beneficial to the successful implantation of the implant in the human body; the combination of electrochemistry and hydrothermal method, the conditions are mild, and the biological performance of the existing implant can be effectively improved.
本发明的目的是通过以下技术方案实现的:The purpose of this invention is to realize through the following technical solutions:
一种钛金属表面钛酸锶/锶羟基磷灰石医用复合涂层的制备方法,包括以下步骤:A preparation method of strontium titanate/strontium hydroxyapatite medical composite coating on titanium metal surface, comprising the following steps:
A、钛预处理A. Titanium pretreatment
将纯度≥99.7%的钛片用SiC砂纸逐级对钛片进行打磨至表面无明显划痕,采用有机试剂,去离子水超声洗涤,混合酸溶液浸泡10-15秒,去离子水超声洗涤干燥;The titanium sheet with a purity of ≥ 99.7% is polished step by step with SiC sandpaper until the surface has no obvious scratches. Organic reagents are used, deionized water is ultrasonically washed, mixed acid solution is soaked for 10-15 seconds, deionized water is ultrasonically washed and dried. ;
B、阳极氧化B. Anodizing
以步骤A预处理后的钛片为阳极,铂片电极为阴极,室温下进行阳极氧化,电解液为0.5wt%的HF溶液,两电极间距保持在5cm,阳极氧化后将钛片清洗干燥,并于管式炉中进行退火处理;The titanium sheet pretreated in step A was used as the anode, the platinum sheet electrode was used as the cathode, and anodization was performed at room temperature. And annealed in a tube furnace;
C、水热反应C. Hydrothermal reaction
将步骤B所得钛片于16ml Sr(OH)2溶液中,200℃下水热反应1.5-2h,取出清洗干燥;The titanium sheet obtained in step B was placed in 16 ml of Sr(OH) 2 solution, hydrothermally reacted at 200 ° C for 1.5-2 h, taken out, washed and dried;
D、电化学沉积D. Electrochemical deposition
将步骤C所得钛片置于钙盐和锶盐混合电解液中进行恒流沉积,所述电解液组成为:0.034M-0.04M的Ca(NO)3,0.02M-0.06M的Sr(NO)3,0.025M的NH4H2PO3,0.1M的Na(NO)3。The titanium sheet obtained in step C is placed in a mixed electrolyte of calcium salt and strontium salt for constant current deposition, and the electrolyte is composed of: 0.034M-0.04M Ca(NO) 3 , 0.02M-0.06M Sr(NO) ) 3 , 0.025M NH4H2PO3 , 0.1M Na(NO )3 .
进一步地,步骤A,所述有机试剂为乙醇和丙酮。Further, in step A, the organic reagents are ethanol and acetone.
进一步地,步骤A,所述混合酸溶液为HF:HNO3:H2O=1:5:10vt%。Further, in step A, the mixed acid solution is HF:HNO 3 :H 2 O=1:5:10vt%.
进一步地,步骤B,所述阳极氧化电压为30V-50V,阳极氧化时间为1-2h。Further, in step B, the anodic oxidation voltage is 30V-50V, and the anodic oxidation time is 1-2h.
进一步地,步骤B,所述退火处理的具体步骤为:将钛片置于管式炉中程序升温,首先设置升温速率为10℃/min,升温至500℃,保持2h,然后随炉冷却至室温。Further, in step B, the specific steps of the annealing treatment are: placing the titanium sheet in a tube furnace to program the temperature, first setting the heating rate to 10°C/min, heating to 500°C, holding for 2 hours, and then cooling with the furnace to 10°C/min. room temperature.
进一步地,步骤C,所述Sr(OH)2溶液的浓度为0.018M-0.025M。Further, in step C, the concentration of the Sr(OH) 2 solution is 0.018M-0.025M.
进一步地,步骤D,所述恒流沉积过程采用三电极体系,以步骤C所得钛片为工作电极,铂电极为对电极,饱和甘汞电极(SCE)为参比电极,其中恒流沉积电流密度为0.8-2mA/cm2,沉积时间为40-60min。Further, in step D, the constant current deposition process adopts a three-electrode system, the titanium sheet obtained in step C is used as the working electrode, the platinum electrode is used as the counter electrode, and the saturated calomel electrode (SCE) is used as the reference electrode, wherein the constant current deposition current The density was 0.8-2 mA/cm 2 and the deposition time was 40-60 min.
更进一步地,所述电解液PH值保持在4.5,沉积温度保持在65℃,并采用磁力搅拌。Further, the pH value of the electrolyte was kept at 4.5, the deposition temperature was kept at 65°C, and magnetic stirring was used.
与现有技术相比,本发明的有益效果在于:本发明首次在钛基体表面制备了含锶元素复合涂层,其中分为含锶纳米管涂层和含锶羟基磷灰石涂层;复合涂层中锶逐渐释放到人体环境中,能够发挥锶离子在骨修复方面的作用;其次,羟基磷灰石表面粗糙形貌也有利于成骨细胞定殖;其中,选择管状二氧化钛涂层也能够加强复合涂层同基底的机械嵌合,能够解决现有涂层易脱落的现实问题。Compared with the prior art, the beneficial effects of the present invention are: the present invention prepares a strontium element-containing composite coating on the surface of the titanium substrate for the first time, which is divided into a strontium-containing nanotube coating and a strontium-containing hydroxyapatite coating; The strontium in the coating is gradually released into the human environment, which can play the role of strontium ions in bone repair; secondly, the rough surface morphology of hydroxyapatite is also conducive to the colonization of osteoblasts; among them, the choice of tubular titanium dioxide coating can also Strengthening the mechanical fit between the composite coating and the substrate can solve the practical problem that the existing coating is easy to fall off.
附图说明Description of drawings
图1实施例1中二氧化钛纳米管涂层的电镜图;The electron microscope picture of titanium dioxide nanotube coating in Fig. 1 embodiment 1;
图2实施例1中钛酸锶涂层的电镜图;The electron microscope picture of strontium titanate coating in Fig. 2 embodiment 1;
图3实施例1扫描电镜图。Fig. 3 is a scanning electron microscope image of Example 1.
具体实施方式Detailed ways
实施例1Example 1
将厚度为1mm的钛板裁成10x10mm大小钛片,采用400、800、1200砂纸逐级打磨钛片表面,直至钛片表面光滑无明显划痕。后将钛片分别浸入10ml乙醇、丙酮、去离子水并超声清洗10min,清洗干燥,以出去钛片表面杂质。然后,配制体积比为1:5:10的HF、HNO3、H2O的混合溶液,将钛片浸入混酸10-15s,以除去表面金属氧化膜,清洗干燥。Cut a titanium plate with a thickness of 1mm into a 10x10mm size titanium sheet, and use 400, 800, 1200 sandpaper to polish the surface of the titanium sheet step by step until the surface of the titanium sheet is smooth and has no obvious scratches. Afterwards, the titanium sheets were immersed in 10 ml of ethanol, acetone, and deionized water, respectively, and ultrasonically cleaned for 10 minutes, and then cleaned and dried to remove impurities on the surface of the titanium sheets. Then, a mixed solution of HF, HNO 3 and H 2 O with a volume ratio of 1:5:10 was prepared, and the titanium sheet was immersed in the mixed acid for 10-15s to remove the surface metal oxide film, washed and dried.
以上述预处理后的钛片做阳极,铂片电极做阴极,0.5wt%的HF溶液中进行阳极氧化。电压50v,氧化时间为1h。清洗干燥后,将钛片进行退火处理,升温速率10℃/min,500℃下保温90min,后随炉冷却,此时得到更为稳定的锐钛矿型二氧化钛。The pretreated titanium sheet was used as the anode, the platinum sheet electrode was used as the cathode, and anodization was carried out in a 0.5 wt% HF solution. The voltage was 50v, and the oxidation time was 1h. After cleaning and drying, the titanium sheet was annealed at a heating rate of 10 °C/min, kept at 500 °C for 90 min, and then cooled in a furnace, at which point more stable anatase titanium dioxide was obtained.
将热处理后的钛片浸入16ml,0.02M的Sr(OH)2溶液中,反应釜选择25ml高压反应釜。200℃下,水热反应进行2h,冷却后去离子水冲洗表面多余溶液,60℃下干燥备用。Immerse the heat-treated titanium sheet in 16ml, 0.02M Sr(OH) 2 solution, and select a 25ml autoclave for the reaction kettle. At 200 °C, the hydrothermal reaction was carried out for 2 h. After cooling, the excess solution on the surface was rinsed with deionized water, and dried at 60 °C for use.
以上述水热反应后的钛片做基底进行一步恒流沉积。电解液组成为0.034M Ca(NO)3,0.06MSr(NO)3,0.025M NH4H2PO3,0.1M Na(NO)3。将电解液调ph值为4.5,进行电化学沉积时,使温度保持在65℃,同时伴随磁力搅拌。沉积电流选择1mA/cm2,沉积时间40mim。One-step constant-current deposition was performed using the above-mentioned hydrothermally reacted titanium sheet as a substrate. The electrolyte composition was 0.034M Ca(NO) 3 , 0.06MSr(NO) 3 , 0.025M NH 4 H 2 PO 3 , and 0.1M Na(NO) 3 . The pH of the electrolyte was adjusted to 4.5, and the temperature was maintained at 65° C. with magnetic stirring during electrochemical deposition. The deposition current is 1 mA/cm 2 , and the deposition time is 40 mim.
实施例2Example 2
将厚度为1mm的钛板裁成10x10mm大小钛片,采用400、800、1200砂纸逐级打磨钛片表面,直至钛片表面光滑无明显划痕。后将钛片分别浸入10ml乙醇、丙酮、去离子水并超声清洗10min,清洗干燥,以出去钛片表面杂质。然后配制体积比为1:5:10的HF、HNO3、H2O的混合溶液,将钛片浸入混酸10-15s,以除去表面金属氧化膜,清洗干燥。Cut a titanium plate with a thickness of 1mm into a 10x10mm size titanium sheet, and use 400, 800, 1200 sandpaper to polish the surface of the titanium sheet step by step until the surface of the titanium sheet is smooth and has no obvious scratches. Afterwards, the titanium sheets were immersed in 10 ml of ethanol, acetone, and deionized water, respectively, and ultrasonically cleaned for 10 minutes, and then cleaned and dried to remove impurities on the surface of the titanium sheets. Then, a mixed solution of HF, HNO 3 and H 2 O with a volume ratio of 1:5:10 was prepared, and the titanium sheet was immersed in the mixed acid for 10-15s to remove the surface metal oxide film, washed and dried.
以上述预处理后的钛片做阳极,铂片电极做阴极,0.5wt%的HF溶液中进行阳极氧化。电压60v,氧化时间为2h。清洗干燥后,将钛片进行退火处理,升温速率10℃/min,500℃下保持90min,后随炉冷却,此时得到更为稳定的锐钛矿型二氧化钛。The pretreated titanium sheet was used as the anode, the platinum sheet electrode was used as the cathode, and anodization was carried out in a 0.5 wt% HF solution. The voltage was 60v, and the oxidation time was 2h. After cleaning and drying, the titanium sheet was annealed at a heating rate of 10 °C/min, kept at 500 °C for 90 min, and then cooled in a furnace, at which point more stable anatase titanium dioxide was obtained.
将热处理后的钛片浸入16ml,0.025M Sr(OH)2溶液中,反应釜选择25ml高压反应釜。200℃下,水热反应进行2h,冷却后去离子水冲洗表面多余溶液,60℃下干燥备用。Immerse the heat-treated titanium sheet in 16ml, 0.025M Sr(OH) 2 solution, and select a 25ml high-pressure reactor for the reaction kettle. At 200 °C, the hydrothermal reaction was carried out for 2 h. After cooling, the excess solution on the surface was rinsed with deionized water, and dried at 60 °C for use.
以上述水热反应后的钛片做基底进行一步恒流沉积。电解液组成为0.04M的Ca(NO)3,0.02M的Sr(NO)3,0.025M NH4H2PO3,0.1M Na(NO)3。将电解液调ph值为4.5,进行电化学沉积时,使温度保持在65℃,同时伴随磁力搅拌。沉积电流选择2mA/cm2,沉积时间60mim。One-step constant-current deposition was performed using the above-mentioned hydrothermally reacted titanium sheet as a substrate. The electrolyte composition was 0.04M Ca(NO) 3 , 0.02M Sr(NO) 3 , 0.025M NH 4 H 2 PO 3 , 0.1M Na(NO) 3 . The pH of the electrolyte was adjusted to 4.5, and the temperature was maintained at 65° C. with magnetic stirring during electrochemical deposition. The deposition current is 2mA/cm 2 and the deposition time is 60mim.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010822010.9A CN112121227A (en) | 2020-08-15 | 2020-08-15 | Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010822010.9A CN112121227A (en) | 2020-08-15 | 2020-08-15 | Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112121227A true CN112121227A (en) | 2020-12-25 |
Family
ID=73851639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010822010.9A Pending CN112121227A (en) | 2020-08-15 | 2020-08-15 | Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112121227A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112875665A (en) * | 2021-02-07 | 2021-06-01 | 吉林大学 | Hydroxyapatite microspheres for injection filling preparation and preparation method thereof |
CN113151828A (en) * | 2021-03-05 | 2021-07-23 | 中山大学 | Biological coating with osteogenic and antibacterial functions on titanium alloy surface and preparation method and application thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10110293A (en) * | 1996-10-03 | 1998-04-28 | Nikon Corp | Production of strontium apatite coating |
CN1927410A (en) * | 2006-09-25 | 2007-03-14 | 华南理工大学 | Strontium containing hydroxyapatite biologically active film and preparation method thereof |
CN101603195A (en) * | 2009-06-22 | 2009-12-16 | 浙江大学 | Electrochemical Method for Preparing Strontium-doped Hydroxyapatite Coating on Titanium Surface |
WO2014174437A1 (en) * | 2013-04-22 | 2014-10-30 | Sandvik Intellectual Property Ab | Method for drug loading hydroxyapatite coated implant surfaces |
CN108505097A (en) * | 2018-04-03 | 2018-09-07 | 吉林大学 | A kind of preparation method of 3D printing titanium/titania nanotube/hydroxyapatite composite medical material |
CN110013565A (en) * | 2019-03-29 | 2019-07-16 | 西安理工大学 | A kind of preparation method of biological piezoelectric coating on titanium alloy surface |
KR20200066867A (en) * | 2018-12-03 | 2020-06-11 | 조선대학교산학협력단 | Coating method of bioactive elements of nano-mesh type titanium-based alloy using a plasma electrolytic oxidation method |
-
2020
- 2020-08-15 CN CN202010822010.9A patent/CN112121227A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10110293A (en) * | 1996-10-03 | 1998-04-28 | Nikon Corp | Production of strontium apatite coating |
CN1927410A (en) * | 2006-09-25 | 2007-03-14 | 华南理工大学 | Strontium containing hydroxyapatite biologically active film and preparation method thereof |
CN101603195A (en) * | 2009-06-22 | 2009-12-16 | 浙江大学 | Electrochemical Method for Preparing Strontium-doped Hydroxyapatite Coating on Titanium Surface |
WO2014174437A1 (en) * | 2013-04-22 | 2014-10-30 | Sandvik Intellectual Property Ab | Method for drug loading hydroxyapatite coated implant surfaces |
CN108505097A (en) * | 2018-04-03 | 2018-09-07 | 吉林大学 | A kind of preparation method of 3D printing titanium/titania nanotube/hydroxyapatite composite medical material |
KR20200066867A (en) * | 2018-12-03 | 2020-06-11 | 조선대학교산학협력단 | Coating method of bioactive elements of nano-mesh type titanium-based alloy using a plasma electrolytic oxidation method |
CN110013565A (en) * | 2019-03-29 | 2019-07-16 | 西安理工大学 | A kind of preparation method of biological piezoelectric coating on titanium alloy surface |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112875665A (en) * | 2021-02-07 | 2021-06-01 | 吉林大学 | Hydroxyapatite microspheres for injection filling preparation and preparation method thereof |
CN112875665B (en) * | 2021-02-07 | 2022-11-01 | 吉林大学 | Hydroxyapatite microspheres for injection filling preparation and preparation method thereof |
CN113151828A (en) * | 2021-03-05 | 2021-07-23 | 中山大学 | Biological coating with osteogenic and antibacterial functions on titanium alloy surface and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110152056B (en) | A method for rapidly introducing functional ions on the surface of titanium alloys | |
CN103110981B (en) | Method for preparing antibacterial active titanium oxide nanotube array composite coating material | |
CN103736148B (en) | The method preparing titanium implant and the titanium implant obtained | |
CN102908661B (en) | Medical titanium with a trace element slow-release function or titanium alloy implant material as well as preparation method and application of same | |
CN101570874B (en) | The Method of Forming TiO2/HA/CaCO3 Gradient Film Layer in Situ | |
CN113502524B (en) | Preparation method of medical titanium alloy surface biological piezoelectric antibacterial coating | |
CN105903076A (en) | Preparation method of dental implant and composite surface thereof | |
CN102743789B (en) | Artificial tooth root with micro-nano hierarchical topologic surface structure and preparation method of artificial tooth root | |
CN101302638A (en) | A kind of preparation method of nano HAP coating/magnesium alloy composite biological material | |
CN108505097B (en) | A preparation method of 3D printing titanium/titanium dioxide nanotube/hydroxyapatite composite medical material | |
CN110338921B (en) | Dental implant and preparation method thereof | |
CN104726921A (en) | Titanium dioxide/strontium and fluorine-containing hydroxyapatite bioactive nano-composite coating as well as preparation method and application thereof | |
CN103361702A (en) | Method for surface modification of dental implant | |
TWI480026B (en) | Bio-implant having screw body selectively formed with nanoporous in spiral groove and method of making the same | |
CN104888271A (en) | Method for preparing strontium-containing hydroxyapatite coating on surface of biodegradable magnesium alloy | |
CN101703797A (en) | Fluorine-substituted apatite coating on surface of biologic medical magnesium or alloy thereof and preparation method | |
CN100423794C (en) | Active biological piezoelectric ceramic coating and method for preparing the coating on the surface of titanium substrate | |
CN112121227A (en) | Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface | |
CN101491692A (en) | Preparation method of calcium titanate nano-tube array biological coatings | |
CN113248249B (en) | Method for preparing titanium alloy surface hydroxyapatite bioceramic by sol-gel method | |
CN118147620B (en) | Preparation method of active contact antibacterial coating on titanium alloy surface | |
CN118653193A (en) | Method for preparing zinc-containing antibacterial coating on the surface of medical implant material | |
CN101161295A (en) | Method for modifying medical metallic grafting body surface collagen by galvano-chemistry method | |
CN105420796B (en) | The modified coating and preparation method of magnesium-based surface carbon nanotubes-hydroxyapatite | |
CN108166036A (en) | A kind of new method that fluorine-containing nano hydroxyapatite coating is prepared on biological medical magnesium alloy surface |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201225 |
|
WD01 | Invention patent application deemed withdrawn after publication |